SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950142-24-001425
Filing Date
2024-05-24
Accepted
2024-05-24 16:48:23
Documents
2
Period of Report
2024-05-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es240464229_3-manhard.html 3  
1 OWNERSHIP DOCUMENT es240464229_3-manhard.xml 3 1671
2 EXHIBIT 24.1 es240464229_ex2401.htm EX-24.1 10217
  Complete submission text file 0000950142-24-001425.txt   13499
Mailing Address C/O HERON THERAPEUTICS, INC 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
MANHARD KIMBERLY (Reporting) CIK: 0001202094 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42031 | Film No.: 24985203

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Issuer) CIK: 0002007919 (see all company filings)

IRS No.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)